Updated: January 21, 2026
Zurzuvae Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

- Boxed Warning: Driving Impairment
- Most Common Side Effects of Zurzuvae
- Serious Side Effects: When to Call Your Doctor or Seek Emergency Care
- Side Effects That Require a Dose Reduction
- Physical Dependence and Withdrawal
- Tips for Managing Side Effects During Your 14-Day Course
- Finding Zurzuvae If You Need a Refill or Replacement
Overview
Zurzuvae (zuranolone) causes drowsiness in about 36% of patients. Here's a full rundown of side effects, boxed warnings, and when to call your doctor.
Is Zurzuvae in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Zurzuvae near you.
Zurzuvae (zuranolone) is the only FDA-approved oral medication for postpartum depression (PPD), and its side effect profile is directly related to how it works: by enhancing the activity of GABA-A receptors—the brain's primary inhibitory signaling system. Understanding what to expect can help you manage the 14-day treatment course confidently and know when to reach out to your healthcare provider.
Boxed Warning: Driving Impairment
Zurzuvae carries a
boxed warning—the FDA's most serious warning—about driving impairment. Zurzuvae causes CNS depressant effects that can impair your ability to drive and operate heavy machinery. Critically, you may not be able to accurately judge your own degree of impairment.
Rule: Do not drive or operate heavy machinery for at least 12 hours after each dose for the entire 14-day treatment course—not just the first few nights.
Because Zurzuvae is taken in the evening, most patients take it before bed and sleep through the most intense sedation window. However, plan ahead: if you need to drive the morning after a dose, factor in the 12-hour window.
Check live stock now.
Most Common Side Effects of Zurzuvae
In the Phase 3 SKYLARK clinical trial (Study 1, 50 mg Zurzuvae), the following adverse reactions occurred in 5% or more of patients and at a higher rate than placebo:
- Somnolence / drowsiness: 36% of Zurzuvae patients vs. 6% on placebo. The most frequently reported and most impactful side effect. Occurs because zuranolone enhances GABA-A activity, which has an inhibitory (calming/sedating) effect on the brain.
- Dizziness: Approximately 13% of patients. Risk of falls is elevated—take care when standing up from bed or a chair.
- Diarrhea: Reported in a meaningful subset of patients. Usually mild.
- Fatigue: Tiredness beyond typical new-parent exhaustion may occur, especially in the first several days.
- Nasopharyngitis (common cold symptoms): Upper respiratory symptoms such as runny nose, congestion, and mild sore throat.
- Urinary tract infection (UTI): Reported in some patients. If you develop painful urination, urgency, or fever, contact your provider promptly.
Serious Side Effects: When to Call Your Doctor or Seek Emergency Care
Several serious adverse effects require immediate attention:
- Suicidal thoughts or behaviors: As with all antidepressants, Zurzuvae carries a warning about new or worsening suicidal thoughts or behaviors. If you experience these, call your doctor immediately or go to the nearest emergency room. You can also call or text 988 (Suicide & Crisis Lifeline).
- Confusion or confusional state: Occurred in 1% of patients across clinical studies. If you feel acutely disoriented or confused, stop activities that require alertness and contact your provider.
- Severe allergic reaction: Rash, hives, swelling of the face, lips, or throat, or difficulty breathing. Seek emergency care immediately.
- Signs of breathing difficulty: If combined with alcohol, opioids, or benzodiazepines, Zurzuvae can cause additive CNS depression including respiratory depression. Avoid these combinations.
Side Effects That Require a Dose Reduction
In Study 1, 14% of Zurzuvae-treated patients required a dose reduction due to adverse reactions. The most common reasons were somnolence and confusional state. If side effects are difficult to tolerate, don't stop the medication without talking to your provider first—a dose reduction may allow you to continue treatment comfortably.
Physical Dependence and Withdrawal
Zurzuvae can produce physical dependence, even over the 14-day treatment course. Withdrawal symptoms reported in studies include: insomnia, palpitations, decreased appetite, nightmares, nausea, excessive sweating, and paranoia. These were generally mild-to-moderate in severity. Do not abruptly stop Zurzuvae mid-course without discussing it with your provider.
Tips for Managing Side Effects During Your 14-Day Course
- Take Zurzuvae in the evening with a fatty meal to optimize absorption and sleep through the peak sedation window
- Arrange childcare support for morning tasks that require alertness or driving
- Avoid alcohol entirely during the 14-day course—it significantly worsens CNS depression
- Rise slowly from bed—dizziness can increase fall risk
Tell all your providers (including dentists) that you're taking Zurzuvae before any new medication is prescribed. See our full drug interaction guide: Zurzuvae Drug Interactions: What to Avoid.
Found
Rate
on average
Finding Zurzuvae If You Need a Refill or Replacement
Zurzuvae is only available at specialty pharmacies. If you have trouble filling or re-accessing your prescription, medfinder can help identify which specialty pharmacies are able to fill it and send you results by text.
Frequently Asked Questions
Most side effects from Zurzuvae—including drowsiness, dizziness, and diarrhea—are tied to the 14-day treatment course and typically resolve within a few days of completing the course. Somnolence peaked early in treatment for most patients. If side effects persist or worsen after the treatment ends, contact your healthcare provider.
Zurzuvae causes somnolence (drowsiness) in about 36% of patients. It's taken in the evening, so most sedation occurs while you sleep. However, residual drowsiness or dizziness the next morning is possible. It's strongly recommended to arrange childcare support—especially for the morning hours—during the 14-day course, as driving must be avoided for at least 12 hours after each dose.
No. Alcohol is a CNS depressant and significantly worsens Zurzuvae's CNS depressant effects, including sedation and psychomotor impairment. Clinical studies confirmed that combining Zurzuvae with alcohol increased psychomotor performance impairment. Avoid alcohol entirely during the 14-day treatment course.
Contact your healthcare provider immediately. Some patients may experience worsening depression or new suicidal thoughts during treatment. If you have thoughts of harming yourself, call 911, go to the nearest emergency room, or call/text 988 (Suicide & Crisis Lifeline). Do not stop Zurzuvae without medical guidance, as withdrawal symptoms are possible.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Zurzuvae also looked for:
More about Zurzuvae
38,465 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





